These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8345720)

  • 1. [Expression of HLA class II antigen-associated invariant chain on renal cell cancer].
    Saito T; Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1036-40. PubMed ID: 8345720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Major histocompatibility complex class II antigens on renal cell cancer--immunohistochemical study and effect on their expression by interferon].
    Tomita Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1079-86. PubMed ID: 2120500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
    Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
    Cancer Lett; 1996 Dec; 109(1-2):15-21. PubMed ID: 9020898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
    Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
    Cancer Lett; 1997 May; 115(1):121-7. PubMed ID: 9097987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 (ICAM-1) on renal cell cancer. De novo expression and modulation by cytokines on renal cell cancer cell lines].
    Tomita Y; Nishiyama T; Sato S; Fujiwara M
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):232-8. PubMed ID: 1674973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological study on renal cell carcinoma in dialysis patients with acquired cystic disease of kidneys].
    Onishi T; Machida T; Masuda F; Torii S; Shirakawa H; Hatano T; Makino H
    Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1800-6. PubMed ID: 1762269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I and II antigens expression in patients with renal cell carcinoma.
    Ozgur BC; Gonenc F; Yazicioglu AH
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic markers in renal cell carcinoma.
    Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
    Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
    J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomorphological characteristics of renal cell carcinoma.
    Markovic-Lipkovski J; Brasanac D; Todorovic V; Müller CA; Müller GA
    Histol Histopathol; 1995 Jul; 10(3):651-9. PubMed ID: 7579814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers.
    Menard LC; Fischer P; Kakrecha B; Linsley PS; Wambre E; Liu MC; Rust BJ; Lee D; Penhallow B; Manjarrez Orduno N; Nadler SG
    Front Immunol; 2018; 9():2728. PubMed ID: 30534127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
    Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
    Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
    Dengjel J; Nastke MD; Gouttefangeas C; Gitsioudis G; Schoor O; Altenberend F; Müller M; Krämer B; Missiou A; Sauter M; Hennenlotter J; Wernet D; Stenzl A; Rammensee HG; Klingel K; Stevanović S
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4163-70. PubMed ID: 16857787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma.
    Miura Y; Anami T; Yatsuda J; Motoshima T; Oka S; Suyama K; Inoshita N; Kinowaki K; Urakami S; Kamba T; Komohara Y
    Anticancer Res; 2021 Jun; 41(6):2841-2848. PubMed ID: 34083274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.